GMD — Antisera, Latex Agglutination, Cryptococcus Neoformans Class II
FDA Device Classification
Classification Details
- Product Code
- GMD
- Device Class
- Class II
- Regulation Number
- 866.3165
- Submission Type
- Review Panel
- MI
- Medical Specialty
- Microbiology
- Implant
- No
Recent 510(k) Clearances
| K-Number | Applicant | Device Name | Date |
| K112422 | immuno-mycologics | CRAG LATERAL FLOW ASSAY (LFA) | March 28, 2012 |
| K102286 | immuno-mycologics | CRAG LATERAL FLOW ASSAY (CRAG LFA) | July 20, 2011 |
| K930418 | trinity laboratories | CRYPTO-LEX SYSTEM | February 17, 1994 |
| K933997 | alexon biomedical | PROSPECT ENTAMOEBA HISTOLYTICA MICROPLATE ASSAY | November 22, 1993 |
| K894845 | meridian diagnostics | (CALAS(TM)) W/ADD'L REAGENT CALAS(TM) PRONASE | September 8, 1989 |
| K812188 | american scientific products | CRYPTOCOCCAL ANTIGEN LATEX AGGLUTI | August 31, 1981 |
| K810510 | immuno-mycologics | YA-CRYPTO ANTIBODY TUBE AGGLUTINATION | March 20, 1981 |
| K792693 | meridian diagnostics | CRYPTOCOCCUS NEOFORMANS ANTISERUM, LATEX | January 21, 1980 |
| K791382 | immuno-mycologics | CRYPTOCOCCAL ANTIGEN LATEX AGGLUTINATION | August 16, 1979 |
| K780526 | i m | CRYPTOCOCCAL ANTIGEN LATEX AGG. SYSTEM | April 28, 1978 |